DR. MARC A WARMUTH MD NPI 1265429989

NPI Information

  • NPI: 1265429989
  • Provider Name: DR. MARC A WARMUTH, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 121 WHITEHALL DR
    ST AUGUSTINE, FL
    ZIP 32086
  • Phone: (904) 825-4500

Map and Directions

Get Directions

NPI Details

DR. Marc A Warmuth, MD is a hematology and oncology internal medicine in St Augustine, FL with 34 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Marc A Warmuth, MD NPI is 1265429989. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TEXAS MEDICAL SCHOOL AT HOUSTON
Graduation Year:1991

The provider's business location address is:

121 WHITEHALL DR
ST AUGUSTINE, FL
ZIP 32086-266
Phone: (904) 825-4500
Fax: (904) 825-3672

The NPI 1265429989 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, gadoterate meglumine, 0.1 ml (HCPCS:A9575)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg (HCPCS:Q5122)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Injection, gadobutrol, 0.1 ml (HCPCS:A9585)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Blood creatinine level (HCPCS:82565)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Mri scan of brain before and after contrast (HCPCS:70553)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • Mri scan of abdomen before and after contrast (HCPCS:74183)
  • Ct scan of soft tissue of neck with contrast (HCPCS:70491)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Nuclear medicine study whole body with ct scan (HCPCS:78816)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Mri scan of pelvis before and after contrast (HCPCS:72197)
  • Urinalysis, manual test (HCPCS:81002)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Ct scan of head or brain before and after contrast (HCPCS:70470)

The enumeration date for this NPI number is 9/29/2005 and was last updated on 5/9/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & OncologyME 73421FLORIDAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
15406652OTHERFLORIDAAETNA
2248299OTHERFLORIDAAVMED
3255201900MEDICAIDFLORIDA
441977OTHERFLORIDABCBS

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.